An estimated 10 percent of pharmaceuticals sold worldwide are thought to be counterfeit. And the situation is growing even more critical. Bill McBeath, managing director in the Supply Chain Risk Intelligence Group of Marsh, talks about how companies can approach the issue, through the application of state-of-the-art technology as well as new business processes. Manufacturers must work closely with wholesalers and retailers to ensure the integrity of drugs as they flow through the channel. Establishing a strict chain of custody is essential, especially in light of new government programs that mandate "e-pedigrees" for drugs sold within certain states. McBeath also compares the use of radio frequency identification and barcodes for managing e-pedigrees. [Run Time (Min): 12:17]